Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Geng-wei Huo"'
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 18, Iss 7 (2022)
Cancer patients with autoimmune disease (AID) are usually excluded from clinical trials involving immune checkpoint inhibitors (ICIs). The available electronic databases were systematically searched from inception until July 3, 2022. We recorded the
Externí odkaz:
https://doaj.org/article/571dc5bfcb6249cfa1cdbf7e68421cc2
Autor:
Wen-Ming Chen, Hong-Mei Zhang, Fu-Yi Zhu, Geng-Wei Huo, Peng Chen, Ran Zuo, Wei-Dong Chen, Sha-Sha Jia, Ying Song
Publikováno v:
Translational Cancer Research
Background We conducted a meta-analysis to evaluates the incidence of the gastrointestinal (GI) adverse events with the use of PD-1 inhibitors among patients with advanced non-small cell lung cancer (NSCLC). Methods The PICOs (participants, intervent
Autor:
Ran Zuo, Peng Chen, Ying Song, Geng-Wei Huo, Sha-Sha Jia, Wen-Ming Chen, Wei-Dong Chen, Hong-Mei Zhang, Dao-Qun Chong
Publikováno v:
Open Medicine, Vol 16, Iss 1, Pp 728-736 (2021)
Open Medicine
Open Medicine
This study evaluates the impact of the use of antibiotics on the effectiveness of nivolumab in the treatment of advanced/metastatic non-small cell lung cancer (NSCLC). A literature search was conducted in various electronic databases to identify stud
Publikováno v:
Open Medicine
Open Medicine, Vol 15, Iss 1, Pp 447-456 (2020)
Open Medicine, Vol 15, Iss 1, Pp 447-456 (2020)
This study evaluates the efficacy of pembrolizumab for the treatment of advanced/metastatic melanoma. The literature search was conducted in electronic databases for studies that evaluated the efficacy and safety of pembrolizumab either alone or in c
Autor:
Geng-wei Huo, Ran Zuo, Ying Song, Wei-dong Chen, Wen-ming Chen, Dao-qun Chong, Hong-mei Zhang, Sha-sha Jia, Peng Chen
Publikováno v:
Open Medicine; Jan2021, Vol. 16 Issue 1, p728-736, 9p, 1 Diagram, 3 Charts, 7 Graphs
Publikováno v:
Open Medicine; Jan2020, Vol. 15 Issue 1, p447-456, 10p, 1 Diagram, 2 Charts, 4 Graphs